A rating of 54 puts Halozyme Therapeutics, Inc. (HALO) near the top of the Healthcare sector according to InvestorsObserver. Halozyme Therapeutics, Inc.'s score of 54 means that it ranks higher than 54% of stocks in the sector. In addition, its overall score of 48 ranks it higher than 48% of all stocks.
HALO has an Overall Score of 48. Find out what this means to you and get the rest of the rankings on HALO!